146 related articles for article (PubMed ID: 34459484)
1. Analysis of blood group antigens on MUC5AC in mucinous ovarian cancer tissues using in situ proximity ligation assay.
Mateoiu C; Vitiazeva V; Kristjansdottir B; Weijdegård B; Örnros J; Gallini R; Kamali-Moghaddam M; Sundfeldt K; Karlsson NG
Glycobiology; 2021 Dec; 31(11):1464-1471. PubMed ID: 34459484
[TBL] [Abstract][Full Text] [Related]
2. The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors.
Vitiazeva V; Kattla JJ; Flowers SA; Lindén SK; Premaratne P; Weijdegård B; Sundfeldt K; Karlsson NG
PLoS One; 2015; 10(6):e0130197. PubMed ID: 26075384
[TBL] [Abstract][Full Text] [Related]
3. MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancer.
Rico SD; Schmalfeldt B; Müller V; Wölber L; Witzel I; Paluchowski P; von Leffern I; Heilenkötter U; Jacobsen F; Bernreuther C; Clauditz T; Simon R; Steurer S; Burandt E; Marx AH; Krech T
Pathol Res Pract; 2021 Aug; 224():153533. PubMed ID: 34171599
[TBL] [Abstract][Full Text] [Related]
4. Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.
Pinto R; Carvalho AS; Conze T; Magalhães A; Picco G; Burchell JM; Taylor-Papadimitriou J; Reis CA; Almeida R; Mandel U; Clausen H; Söderberg O; David L
J Cell Mol Med; 2012 Jul; 16(7):1474-84. PubMed ID: 21883895
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas.
Ji H; Isacson C; Seidman JD; Kurman RJ; Ronnett BM
Int J Gynecol Pathol; 2002 Oct; 21(4):391-400. PubMed ID: 12352188
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma.
İlhan Ö; Han Ü; Önal B; Çelık SY
Turk J Gastroenterol; 2010 Dec; 21(4):345-52. PubMed ID: 21331986
[TBL] [Abstract][Full Text] [Related]
7. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
[TBL] [Abstract][Full Text] [Related]
8. Pattern of HER-2 Gene Amplification and Protein Expression in Benign, Borderline, and Malignant Ovarian Serous and Mucinous Neoplasms.
Mohammed RAA; Makboul R; Elsers DAH; Elsaba TMAM; Thalab AMAB; Shaaban OM
Int J Gynecol Pathol; 2017 Jan; 36(1):50-57. PubMed ID: 27309616
[TBL] [Abstract][Full Text] [Related]
9. [Ovarian mucinous tumor of gastric and intestinal type associated with Peutz-Jeghers syndrome: in situ hybridization study of apomucin gene transcripts].
Wacrenier A; Boman F; Farine MO; Durand-Reville M; Buisine MP; Porchet N; Aubert JP; Querleu D; Gosselin B
Ann Pathol; 1998 Dec; 18(6):497-501. PubMed ID: 10051919
[TBL] [Abstract][Full Text] [Related]
10. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
[TBL] [Abstract][Full Text] [Related]
11. MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.
Dong Y; Zhou L; Zhao D; Li K; Liu Z; Che N; Liu H
Jpn J Clin Oncol; 2020 Jun; 50(6):701-711. PubMed ID: 32083303
[TBL] [Abstract][Full Text] [Related]
12. Lectin histochemistry in mucinous and serous ovarian neoplasms.
Sasano H; Saito Y; Nagura H; Kudo R; Rojas M; Silverberg SG
Int J Gynecol Pathol; 1991; 10(3):252-9. PubMed ID: 1655666
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma.
Albarracin CT; Jafri J; Montag AG; Hart J; Kuan SF
Hum Pathol; 2000 Jun; 31(6):672-7. PubMed ID: 10872659
[TBL] [Abstract][Full Text] [Related]
14. The proliferative activity of ovarian tumors of low malignant potential differs from that of ovarian carcinoma.
Nakayama K; Takebayashi Y; Hata K; Fujiwaki R; Iida K; Fukumoto M; Miyazaki K
Anticancer Res; 2003; 23(6C):4657-62. PubMed ID: 14981910
[TBL] [Abstract][Full Text] [Related]
15. A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary.
Chelariu-Raicu A; Holley E; Mayr D; Klauschen F; Wehweck F; Rottmann M; Kessler M; Kaltofen T; Czogalla B; Trillsch F; Mahner S; Schmoeckel E
Int J Gynecol Cancer; 2022 May; 32(5):662-668. PubMed ID: 35185017
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of the chromosome 11 mucin genes in colorectal cancer.
Sylvester PA; Myerscough N; Warren BF; Carlstedt I; Corfield AP; Durdey P; Thomas MG
J Pathol; 2001 Oct; 195(3):327-35. PubMed ID: 11673830
[TBL] [Abstract][Full Text] [Related]
17. Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts.
Cao Z; Maupin K; Curnutte B; Fallon B; Feasley CL; Brouhard E; Kwon R; West CM; Cunningham J; Brand R; Castelli P; Crippa S; Feng Z; Allen P; Simeone DM; Haab BB
Mol Cell Proteomics; 2013 Oct; 12(10):2724-34. PubMed ID: 23836919
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms.
Haab BB; Porter A; Yue T; Li L; Scheiman J; Anderson MA; Barnes D; Schmidt CM; Feng Z; Simeone DM
Ann Surg; 2010 May; 251(5):937-45. PubMed ID: 20395854
[TBL] [Abstract][Full Text] [Related]
19. PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature.
Ates Ozdemir D; Usubutun A
Pathol Oncol Res; 2016 Jul; 22(3):593-9. PubMed ID: 26797858
[TBL] [Abstract][Full Text] [Related]
20. RECQL1 DNA repair helicase: a potential therapeutic target and a proliferative marker against ovarian cancer.
Sanada S; Futami K; Terada A; Yonemoto K; Ogasawara S; Akiba J; Yasumoto M; Sumi A; Ushijima K; Kamura T; Furuichi Y; Yano H
PLoS One; 2013; 8(8):e72820. PubMed ID: 23951333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
